Evrofarma SA (AT:EVROF) — Market Cap & Net Worth
Market Cap & Net Worth: Evrofarma SA (EVROF)
Evrofarma SA (AT:EVROF) has a market capitalization of $52.35 Million (€44.78 Million) as of June 10, 2026. Listed on the AT stock exchange, this Greece-based company holds position #21668 globally and #68 in its home market, demonstrating a -2.27% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Evrofarma SA's stock price €3.88 by its total outstanding shares 13667775 (13.67 Million). Review Evrofarma SA balance sheet liabilities to assess the company's total debt and financial obligations.
Evrofarma SA Market Cap History: 2015 to 2026
Evrofarma SA's market capitalization history from 2015 to 2026. Data shows growth from $4.14 Million to $62.00 Million (28.47% CAGR).
Evrofarma SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Evrofarma SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.25x
Evrofarma SA's market cap is 0.25 times its annual revenue
Latest Price to Earnings (P/E) Ratio
8.02x
Evrofarma SA's market cap is 8.02 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.14 Million | $29.65 Million | $527.00K | 0.14x | 7.85x |
| 2016 | $4.35 Million | $28.91 Million | $412.00K | 0.15x | 10.55x |
| 2017 | $5.27 Million | $30.64 Million | $536.00K | 0.17x | 9.84x |
| 2018 | $10.31 Million | $32.53 Million | $979.00K | 0.32x | 10.53x |
| 2019 | $18.62 Million | $33.48 Million | $157.00K | 0.56x | 118.57x |
| 2020 | $15.24 Million | $33.91 Million | $1.08 Million | 0.45x | 14.11x |
| 2021 | $14.54 Million | $36.70 Million | -$355.00K | 0.40x | N/A |
| 2022 | $11.38 Million | $45.38 Million | $1.42 Million | 0.25x | 8.02x |
Competitor Companies of EVROF by Market Capitalization
Companies near Evrofarma SA in the global market cap rankings as of June 10, 2026.
Key companies related to Evrofarma SA by market ranking:
- Nestlé S.A (F:NESM): Ranked #84 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #99 globally with a market cap of $199.27 Billion USD ( CHF157.62 Billion CHF).
- Danone SA (PA:BN): Ranked #541 globally with a market cap of $49.16 Billion USD ( €42.05 Billion EUR).
- Danone SA (F:BSND): Ranked #688 globally with a market cap of $39.05 Billion USD ( €33.40 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Nestlé S.A | F:NESM | $224.33 Billion | €84.60 |
| #99 | Nestle S.A. | SW:NESN | $199.27 Billion | CHF77.73 |
| #541 | Danone SA | PA:BN | $49.16 Billion | €65.30 |
| #688 | Danone SA | F:BSND | $39.05 Billion | €12.50 |
Evrofarma SA Historical Marketcap From 2015 to 2026
Between 2015 and today, Evrofarma SA's market cap moved from $4.14 Million to $ 62.00 Million, with a yearly change of 28.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €62.00 Million | +7.48% |
| 2025 | €57.68 Million | +99.45% |
| 2024 | €28.92 Million | +50.83% |
| 2023 | €19.17 Million | +68.54% |
| 2022 | €11.38 Million | -21.76% |
| 2021 | €14.54 Million | -4.61% |
| 2020 | €15.24 Million | -18.11% |
| 2019 | €18.62 Million | +80.62% |
| 2018 | €10.31 Million | +95.45% |
| 2017 | €5.27 Million | +21.32% |
| 2016 | €4.35 Million | +5.02% |
| 2015 | €4.14 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 10th, 2026 the market cap of Evrofarma SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $52.35 Million USD |
| MoneyControl | $52.35 Million USD |
| MarketWatch | $52.35 Million USD |
| marketcap.company | $52.35 Million USD |
| Reuters | $52.35 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Evrofarma SA
Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, and cheese products, as well as fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.